Successful phage-antibiotic therapy of P. aeruginosa implant-associated infection in a Siamese cat

References

• Albarellos GA, Ambros LA, Landoni MF. 2008. Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats. Vet J. 178(2):238–243. doi: 10.1016/j.tvjl.2007.06.026.
   PubMed Web of Science ®Google Scholar
• Altamirano FLG, Barr JJ. 2019. Phage therapy in the postantibiotic era. Clin Microbiol Rev. 32(2):e00066-18. doi:10.1128/CMR.00066-18
   Google Scholar
• Burke M, Santoro D. 2023. Prevalence of multidrug-resistant coagulase-positive staphylococci in canine and feline dermatological patients over a 10-year period: a retrospective study. Microbiology (Reading). 169(2):001300. doi: 10.1099/mic.0.001300.
   PubMed Web of Science ®Google Scholar
• Cahill J, Young R. 2019. Phage lysis: multiple genes for multiple barriers. In: Advances in virus research. Vol. 103. Amsterdam: Elsevier; p. 33–70. doi: 10.1016/bs.aivir.2018.09.003.
   Google Scholar
• Caneschi A, Bardhi A, Barbarossa A, Zaghini A. 2023. The use of antibiotics and antimicrobial resistance in veterinary medicine, a complex phenomenon: a narrative review. Antibiotics (Basel). 12(3):487. doi: 10.3390/antibiotics12030487.
   PubMed Web of Science ®Google Scholar
• Dedrick RM, Guerrero-Bustamante CA, Garlena RA, Russell DA, Ford K, Harris K, Gilmour KC, Soothill J, Jacobs-Sera D, Schooley RT, et al. 2019. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med. 25(5):730–733. doi: 10.1038/s41591-019-0437-z.
   PubMed Web of Science ®Google Scholar
• Ferriol-González C, Domingo-Calap P. 2020. Phages for biofilm removal. Antibiotics (Basel). 9(5):268. doi: 10.3390/antibiotics9050268.
   PubMed Web of Science ®Google Scholar
• Feßler AT, Scholtzek AD, Schug AR, Kohn B, Weingart C, Hanke D, Schink A-K, Bethe A, Lübke-Becker A, Schwarz S, et al. 2022. Antimicrobial and biocide resistance among canine and Feline Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii isolates from diagnostic submissions. Antibiotics (Basel). 11(2):152. doi: 10.3390/antibiotics11020152.
   Web of Science ®Google Scholar
• Freitag T, Squires RA, Schmid J. 2008. Naturally occurring bacteriophages lyse a large proportion of canine and feline uropathogenic Escherichia coli isolates in vitro. Res Vet Sci. 85(1):1–7. doi: 10.1016/j.rvsc.2007.09.004.
   PubMed Web of Science ®Google Scholar
• Gelman D, Beyth S, Lerer V, Adler K, Poradosu-Cohen R, Coppenhagen-Glazer S, Hazan R. 2018. Combined bacteriophages and antibiotics as an efficient therapy against VRE Enterococcus faecalis in a mouse model. Res Microbiol. 169(9):531–539. doi: 10.1016/j.resmic.2018.04.008.
   PubMed Web of Science ®Google Scholar
• Genevière J, McCallin S, Huttner A, Pham TT, Suva D. 2021. A systematic review of phage therapy applied to bone and joint infections: an analysis of success rates, treatment modalities and safety. EFORT Open Rev. 6(12):1148–1156. doi: 10.1302/2058-5241.6.210073.
   PubMed Web of Science ®Google Scholar
• Habib I, Mohteshamuddin K, Mohamed MYI, Lakshmi GB, Abdalla A, Bakhit Ali Alkaabi A. 2023. Domestic pets in the United Arab Emirates as reservoirs for antibiotic-resistant bacteria: a comprehensive analysis of extended-spectrum beta-lactamase producing Escherichia coli prevalence and risk factors. Animals (Basel). 13(10):1587. doi: 10.3390/ani13101587.
   PubMedGoogle Scholar
• Hawkins C, Harper D, Burch D, Anggård E, Soothill J. 2010. Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial. Vet Microbiol. 146(3-4):309–313. doi: 10.1016/j.vetmic.2010.05.014.
   PubMed Web of Science ®Google Scholar
• Hillier A, Alcorn JR, Cole LK, Kowalski JJ. 2006. Pyoderma caused by Pseudomonas aeruginosa infection in dogs: 20 Cases. Vet Dermatol. 17(6):432–439. doi: 10.1111/j.1365-3164.2006.00550.x.
   PubMed Web of Science ®Google Scholar
• Husi B, Overesch G, Forterre F, Rytz U. 2023. Surgical site infection after 769 Tibial Plateau leveling osteotomies. Front Vet Sci. 10:1133813. doi: 10.3389/fvets.2023.1133813.
   PubMed Web of Science ®Google Scholar
• Jennes S, Merabishvili M, Soentjens P, Pang KW, Rose T, Keersebilck E, Soete O, François P-M, Teodorescu S, Verween G, et al. 2017. Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury – a case report. Crit Care. 21(1):129. doi: 10.1186/s13054-017-1709-y.
   PubMedGoogle Scholar
• Jin M, Osman M, Green BA, Yang Y, Ahuja A, Lu Z, Cazer CL. 2023. Evidence for the transmission of antimicrobial resistant bacteria between humans and companion animals: a scoping review. One Health. 17:100593. doi: 10.1016/j.onehlt.2023.100593.
   PubMed Web of Science ®Google Scholar
• Ju C, Ma Y, Zhang B, Zhou G, Wang H, Yu M, He J, Duan Y, Zhang M. 2023. Prevalence, genomic characterization and antimicrobial resistance of Campylobacter spp. isolates in pets in Shenzhen, China. Front Microbiol. 14:1152719. doi: 10.3389/fmicb.2023.1152719.
   PubMed Web of Science ®Google Scholar
• Khalifa L, Shlezinger M, Beyth S, Houri-Haddad Y, Coppenhagen-Glazer S, Beyth N, Hazan R. 2016. Phage therapy against Enterococcus faecalis in dental root canals. J Oral Microbiol. 8(1):32157. doi: 10.3402/jom.v8.32157.
   PubMedGoogle Scholar
• Law N, Logan C, Yung G, Furr C-LL, Lehman SM, Morales S, Rosas F, Gaidamaka A, Bilinsky I, Grint P, et al. 2019. Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient. Infection. 47(4):665–668. doi: 10.1007/s15010-019-01319-0.
   PubMed Web of Science ®Google Scholar
• Leite DPdSBM, Barbosa IC, da Silva RA, Fernandes PR, Abad ACA, da Silva JG, Mota RA, Porto TS. Published online 2023. Occurrence of antimicrobial-resistant Staphylococcus aureus in a Brazilian veterinary hospital environment. Braz J Microbiol. 54(3):2393–2401. doi: 10.1007/s42770-023-01035-w.
   PubMed Web of Science ®Google Scholar
• Lerdsittikul V, Thongdee M, Chaiwattanarungruengpaisan S, Atithep T, Apiratwarrasakul S, Withatanung P, Clokie MRJ, Korbsrisate S. 2022. A novel virulent Litunavirus phage possesses therapeutic value against multidrug-resistant Pseudomonas aeruginosa. Sci Rep. 12(1):21193. doi: 10.1038/s41598-022-25576-6.
   PubMed Web of Science ®Google Scholar
• Loponte R, Pagnini U, Iovane G, Pisanelli G. 2021. Phage therapy in veterinary medicine. Antibiotics (Basel). 10(4):421. doi: 10.3390/antibiotics10040421.
   PubMed Web of Science ®Google Scholar
• Marco-Fuertes A, Marin C, Lorenzo-Rebenaque L, Vega S, Montoro-Dasi L. 2022. Antimicrobial resistance in companion animals: a new challenge for the one health approach in the European Union. Vet Sci. 9(5):208. doi: 10.3390/vetsci9050208.
   PubMedGoogle Scholar
• Marshall K, Marsella R. 2023. Topical bacteriophage therapy for Staphylococcal superficial pyoderma in horses: A double-blind, placebo-controlled pilot study. Pathogens. 12(6):828. doi: 10.3390/pathogens12060828.
   PubMed Web of Science ®Google Scholar
• Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Han C, Bisignano C, Rao P, Wool E, et al. 2022. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 399(10325):629–655. doi: 10.1016/S0140-6736(21)02724-0.
   PubMed Web of Science ®Google Scholar
• Nicoll C, Singh A, Weese JS. 2014. Economic impact of Tibial plateau leveling osteotomy surgical site infection in dogs. Vet Surg. 43(8):899–902. doi: 10.1111/j.1532-950X.2014.12175.x.
   PubMed Web of Science ®Google Scholar
• Nielsen SS, Bicout DJ, Calistri P, Canali E, Drewe JA, Garin-Bastuji B, Gonzales Rojas JL, Gortázar C, Herskin M, Michel V, et al. 2022. Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): antimicrobial-resistant Pseudomonas aeruginosa in dogs and cats. Efsa J. 20(5):e07310. doi: 10.2903/j.efsa.2022.7310.
   PubMed Web of Science ®Google Scholar
• Nir-Paz R, Gelman D, Khouri A, Sisson BM, Fackler J, Alkalay-Oren S, Khalifa L, Rimon A, Yerushalmy O, Bader R, et al. 2019. Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination. Clin Infect Dis. 69(11):2015–2018. doi: 10.1093/cid/ciz222.
   PubMed Web of Science ®Google Scholar
• Onallah H, Hazan R, Nir-Paz R, Israeli Phage Therapy Center (IPTC) Study Team. 2023. Compassionate use of bacteriophages for failed persistent infections during the first 5 years of the Israeli phage therapy center. Open Forum Infect Dis. 10(5):ofad221. doi: 10.1093/ofid/ofad221.
   PubMed Web of Science ®Google Scholar
• Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, Liang H, Song X, Wu M. 2022. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther. 7(1):199. doi: 10.1038/s41392-022-01056-1.
   PubMed Web of Science ®Google Scholar
• Rhys-Davies L, Ogden J. 2020. Vets’ and pet owners’ views about antibiotics for companion animals and the use of phages as an alternative. Front Vet Sci. 7:513770. doi: 10.3389/fvets.2020.513770.
   PubMed Web of Science ®Google Scholar
• Rohde C, Resch G, Pirnay J-P, Blasdel BG, Debarbieux L, Gelman D, Górski A, Hazan R, Huys I, Kakabadze E, et al. 2018. Expert opinion on three phage therapy related topics: bacterial phage resistance, phage training and prophages in bacterial production strains. Viruses. 10(4):178. doi: 10.3390/v10040178.
   PubMed Web of Science ®Google Scholar
• Santos HH, Clark J, Terwilliger A, Maresso A. 2022. Discovery of the first lytic Staphylococcus pseudintermedius/Staphylococcus aureus polyvalent bacteriophages. Phage (New Rochelle). 3(2):116–124. doi: 10.1089/phage.2022.0004.
   PubMedGoogle Scholar
• Schmökel H. 2023. Balancing the prevention of surgical site infections with responsible antimicrobial use in companion animal practice. Vet Rec. 192(8):330–331. doi: 10.1002/vetr.2976.
   PubMed Web of Science ®Google Scholar
• Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, et al. 2017. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother. 61(10):e00954–17. doi: 10.1128/AAC.00954-17.
   PubMed Web of Science ®Google Scholar
• Sharma D, Pakravan N, Pritchard JC, Hartmann FA, Young KM. 2019. Mucoid Pseudomonas aeruginosa infection in a cat with severe chronic rhinosinusitis. Vet Clin Pathol. 48(2):300–304. doi: 10.1111/vcp.12749.
   PubMed Web of Science ®Google Scholar
• Sobkowich KE, Weese JS, Poljak Z, Plum A, Szlosek D, Bernardo TM. 2023. Epidemiology of companion animal AMR in the United States of America: filling a gap in the one health approach. Front Public Health. 11:1161950. doi: 10.3389/fpubh.2023.1161950.
   PubMed Web of Science ®Google Scholar
• Summer EJ. 2009. Preparation of a phage DNA fragment library for whole genome shotgun sequencing. Bacteriophages Methods Mol Biol. 502:27–46. doi: 10.1007/978-1-60327-565-1_4
   Google Scholar
• Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, et al. 2018. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 18(3):318–327. doi: 10.1016/S1473-3099(17)30753-3.
   PubMed Web of Science ®Google Scholar
• Uyttebroek S, Chen B, Onsea J, Ruythooren F, Debaveye Y, Devolder D, Spriet I, Depypere M, Wagemans J, Lavigne R, et al. 2022. Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review. Lancet Infect Dis. 22(8):e208–e220. doi: 10.1016/S1473-3099(21)00612-5.
   PubMed Web of Science ®Google Scholar
• Wittmann J, Turner D, Millard AD, Mahadevan P, Kropinski AM, Adriaenssens EM. 2020. From orphan phage to a proposed new family–the diversity of N4-like viruses. Antibiotics. 9(10):1–12. doi: 10.3390/antibiotics9100663.
   Google Scholar
• Yaovi AB, Sessou P, Tonouhewa ABN, Hounmanou GYM, Thomson D, Pelle R, Farougou S, Mitra A. 2022. Prevalence of antibiotic-resistant bacteria amongst dogs in Africa: a meta-analysis review. Onderstepoort J Vet Res. 89(1):e1–e12. doi: 10.4102/ojvr.v89i1.1970.
   PubMedGoogle Scholar
• Yerushalmy O, Braunstein R, Alkalay-Oren S, Rimon A, Coppenhagn-Glazer S, Onallah H, Nir-Paz R, Hazan R. 2023. Towards standardization of phage susceptibility testing: the Israeli phage therapy center “Clinical Phage Microbiology” - a pipeline proposal. Clin Infect Dis. 77(Suppl 5):S337–S351. doi: 10.1093/cid/ciad514.
   PubMedGoogle Scholar
• Yerushalmy O, Khalifa L, Gold N, Rakov C, Alkalay-Oren S, Adler K, Ben-Porat S, Kraitman R, Gronovich N, Shulamit Ginat K, et al. 2020. The Israeli phage bank (IPB). Antibiotics (Basel). 9(5):269. doi: 10.3390/antibiotics9050269.
   PubMed Web of Science ®Google Scholar
• Young MJ, Hall LML, Merabishvilli M, Pirnay JP, Clark JR, Jones JD. 2023. Phage therapy for diabetic foot infection: a case series. Clin Ther. 45(8):797–801. doi: 10.1016/j.clinthera.2023.06.009.
   PubMed Web of Science ®Google Scholar